Diabetic Medicine

RD Lawrence Lecture 2008 Targeting GLP-1 release as a potential strategy for the therapy of Type 2 diabetes
pp. 889-894(6)
Author: Gribble, F. M.

HbA_1c: the case for using estimated average glucose (eAG)
pp. 895-898(4)
Author: Home, P. D.

Estimated average glucose (eAG): fit for purpose?
pp. 899-901(3)
Author: Kilpatrick, E. S.

The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals
pp. 902-908(7)
Authors: Montagnana, M.; Fava, C.; Nilsson, P. M.; Engström, G.; Hedblad, B.; Lippi, G.; Minuz, P.; Berglund, G.; Melander, O.

Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting
pp. 909-915(7)
Authors: Sathyapalan, T.; Atkin, S. L.; Kilpatrick, E. S.

Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients—The PREDICTIVE™ BMI clinical trial
pp. 916-923(8)
Authors: Montañana, C. Fajardo; Herrero, C. Hernández; Fernández, M. Rivas

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials
pp. 924-932(9)
Authors: Bazzano, L. A.; Lee, L. J.; Shi, L.; Reynolds, K.; Jackson, J. A.; Fonseca, V.

Weight history of patients with newly diagnosed Type 2 diabetes
pp. 933-941(9)
Authors: de Fine Olivarius, N.; Richelsen, B.; Siersma, V.; Andreasen, A. H.; Beck-Nielsen, H.

Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population
pp. 942-948(7)
Authors: Edge, J. A.; James, T.; Shine, B.

Leptin—a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes
pp. 949-955(7)
Authors: Wallander, M.; Söderberg, S.; Norhammar, A.

A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years
pp. 956-959(4)
Authors: Pronina, E. A.; Petraikina, E. E.; Antsiferov, M. B.; Duchareva, O.V.; Petrone, A.; Buzzetti, R.; Pozzilli, P.

MEASURE IT, IMPROVE IT: the Safer Patients Initiative and quality improvement in subcutaneous insulin therapy for hospital in-patients
pp. 960-967(8)
Authors: Rushmer, R.; Voigt, D.

Glycaemic control and diabetes care utilization in young adults with Type 1 diabetes
pp. 968-973(6)
Authors: Sparud-Lundin, C.; Öhrn, I.; Danielson, E.; Forsander, G.

A comparison of diabetes clinics with different emphasis on routine care, complications assessment and shared care
pp. 974-978(5)
Authors: Cheung, N. W.; Yue, D. K.; Kotowicz, M. A.; Jones, P. A.; Flack, J. R.

Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey
pp. 979-984(6)
Authors: Esposito, S.; Leone, S.; Noviello, S.; Fiore, M.; Ianniello, F.; Felaco, F. M.; Romagnoli, F.; Sarli, E.

Educational interventions for migrant South Asians with Type 2 diabetes: a systematic review
pp. 985-992(8)
Authors: Khunti, K.; Camosso-Stefinovic, J.; Carey, M.; Davies, M. J.; Stone, M. A.

Perinatal outcomes associated with the use of glargine during pregnancy
pp. 993-996(4)
Authors: Di Cianni, G.; Torlone, E.; Lencioni, C.; Bonomo, M.; Di Benedetto, A.; Napoli, A.; Vitacolonna, E.; Mannino, D.; Lapolla, A.

Diagnostic value of glycated haemoglobin (HbA_1c) for the early detection of diabetes in high-risk subjects
pp. 997-1000(4)
Authors: Kim, K.-S.; Kim, S.-K.; Lee, Y.-K.; Park, S.-W.; Cho, Y.-W.

Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes
pp. 1001-1005(5)
Authors: Currie, D.; Maxwell, A. P.; Sadlier, D.; McKnight, A. J.

Hyperglycaemia induced QT interval duration: a key to the increased risk of sudden death in diabetic patients?
pp. 1006-1006(1)
Authors: Andrássy, G.; Barna, G.; Szabo, A.

Authors' response
pp. 1007-1008(2)
Authors: Gordin, D.; Forsblom, C.; Rönnback, M.; Groop, P.-H.

Severe, delayed insulin detemir injection site reaction
pp. 1008-1008(1)
Author: Blumer, Ian

Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes
pp. 1008-1010(3)
Authors: Oka, R.; Yagi, K.; Hifumi, S.; Miyamoto, S.; Mabuchi, H.; Yamagishi, M.; Takeda, Y.; Inazu, A.; Nohara, A.; Kawashiri, M.; Kobayashi, J.

The effect of diabetes mellitus on the prevalence of rheumatoid arthritis: a case-control study
pp. 1010-1011(2)
Authors: Tentolouris, N.; Arapostathi, C.; Voulgari, C.; Grammatikou, S.; Andrianakos, A.; Sfikakis, P. P.

Type 1 Diabetes: Answers at Your Fingertips
pp. 1012-1012(1)
Author: Surridge, A.

Type 2 Diabetes: Answers at Your Fingertips
pp. 1012-1012(1)
Author: Wood, L.